Navigation Links
BioXcel Forms a Corporate Advisory Board for Its Next Phase of Growth
Date:10/8/2008

NEW HAVEN, Conn., Oct. 8 /PRNewswire/ -- BioXcel Corporation today announced the appointment of three distinguished biopharma executives to its Corporate Advisory Board (CAB). R. Christopher Seaton, SVP of Global Transactions, Bayer Healthcare, Martha Matteo, Ph.D., Past President of SCIP and recently retired from Boehringer Ingelheim Pharmaceuticals, Inc., where she was the Director for Knowledge Management, and Kevin Rakin, Chairman and CEO of Advanced BioHealing, Inc., are known throughout the biopharma world as outstanding and highly experienced pharmaceutical professionals.

BioXcel, a global, business/IP analytics company, will work closely with these industry leaders to design and develop new strategies for its next phase of corporate growth -- targeted to the pharmaceutical, biotechnology, medical device, diagnostic, investment, legal, and related support industries.

"We are delighted to be associated with such a high caliber of experienced pharmaceutical executives," said Vimal D. Mehta, Chairman and co-founder of BioXcel. "Their presence on BioXcel's CAB will assure our planned corporate growth and development at every point in our business model -- from assisting clients with R&D services to all the commercial challenges facing today's complex global industries. BioXcel's senior management, executives, and staff join me in welcoming Christopher, Martha, and Kevin to our valued advisor group. With their advice and guidance, BioXcel is now positioned to achieve our next level of planned business growth, maturity, and service capabilities."

About BioXcel Corporation (http://www.bioxcel.com)

Headquartered in New Haven, CT, BioXcel offers business analytics and intellectual property services to the healthcare sector, life science companies, and related industries worldwide. BioXcel's unique, hybrid delivery model capitalizes on US-based expertise and the BioXcel Analytical and Commercial Center (BACC) in India. This "on-shore/off-shore model" leverages highly flexible analytics teams (MS, MTech, PhDs, MDs, Patent Agents, and MBAs) to provide quality services with outstanding breadth and depth.

For additional information, contact:

Krishnan Nandabalan, Ph.D.

1.203.458.1435

knandabalan@bioxcel.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioXcel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioXcel Expands Its Capability in Business Analytics Support Services
2. NASA technology forms the basis for a new nanotechnology company
3. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
4. iGuard Transforms Drug Safety Alert and Update Process
5. ADM Forms Industrial Chemicals Group
6. Transgenomic, Inc. Forms Scientific Advisory Board
7. Anthera Pharmaceuticals Forms Scientific Advisory Board
8. Technology Transforms Market Research in Pharmaceutical Industry
9. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
10. febit Forms Scientific Advisory Board
11. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... formation of its Medical/Clinical Advisory Board.  This new ... who enhance the range and depth of expertise ... its novel prenatal diagnostic tests.  These experts are ... guidance for the company,s product development and commercialization ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
(Date:1/19/2017)... , ... January 19, 2017 , ... FireflySci Inc. is ... rate. The tremendous growth is accounted to two main factors. The first ... the expanding network of vendors supplying FireflySci products all around the world. , 2016 ...
Breaking Biology Technology:
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):